IRWD:NASDAQ, Ironwood Pharmaceuticals, Inc.

IRWD stock overview

Ironwood Pharmaceuticals, Inc. (IRWD:NASDAQ) closed at $4.87 on November 11, 2026, up 1.25% on the day. The stock trades 15.7% below its 52-week high of $5.78 and 65.1% above its 52-week low of $2.95. Over the past year, it gained 56.6%. Ironwood Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).

Key figures

Price
$4.87
Day change
+1.25%
Volume
2,820,760
Average volume
2,021,406
Market cap
806M+
52-week range
$2.95 – $5.78
50-day average
$3.95
200-day average
$3.95

Price action over the past year

In 252 trading sessions since November 11, 2025, IRWD closed higher on 122 days (48%). Its best day was January 2, 2026 (+26.71%) and its worst was February 20, 2026 (-14.10%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

IRWD news

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a commercial biotechnology company, engages in the research, development, and commercialization of human therapeutic products. The company markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Constella name in the European Union; and lesinurad for the treatment of hyperuricemia associated with uncontrolled gout under ZURAMPIC and DUZALLO names. It has collaboration agreements with Allergan plc and AstraZeneca AB to develop and commercialize linaclotide for the treatment of IBS-C, CIC, and other GI conditions in North America, China, Hong Kong, and Macau; and license agreement with Astellas Pharma Inc. to develop and commercialize linaclotide for the treatment of IBS-C, chronic constipation, and other GI conditions in Japan. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was founded in 1998 and is headquartered in Cambridge, Massachusetts.

Similar stocks

Find more stocks like IRWD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.